LaSota株与基因VII型新城疫病毒(NDV)的抗原变异及其对强毒NDV攻毒的效力
本研究系统分析基因VII型NDV aSG10与商品疫苗株LaSota的抗原变异,并通过血清学与动物试验评估两者对强毒NDV攻毒的效力。结果显示两株病毒抗原性可区分,交叉反应R值为0.23,aSG10疫苗对基因VII型NDV的保护率显著高于LaSota疫苗,且经眼滴/鼻内途径攻毒时鸡群需更高HI抗体水平才能获得充分保护。
要点
- aSG10与LaSota抗原性可区分,交叉反应R值为0.23,属同一血清型内抗原差异较大。
- aSG10疫苗对基因VII型NDV攻毒的保护率显著高于LaSota疫苗,无论肌内或眼滴/鼻内攻毒途径。
- 眼滴/鼻内攻毒时鸡群需更高HI抗体水平才能获得充分保护,高于肌内攻毒。
核心结论
- aSG10与LaSota抗原性可区分,交叉反应R值为0.23,提示二者在同一血清型内存在较大抗原差异。
- aSG10疫苗对基因VII型NDV攻毒的保护率显著高于LaSota疫苗,无论肌内或眼滴/鼻内攻毒途径。
- 与肌内攻毒相比,眼滴/鼻内自然途径攻毒时鸡群需更高HI抗体水平才能获得充分保护。
研究设计与样本
- 通过血清学分析与动物试验,系统分析基因VII型NDV aSG10与商品疫苗株LaSota的抗原变异并评估攻毒效力。
主要发现
- 抗aSG10高免血清对aSG10病毒的HI滴度为11.13±0.30log2,对LaSota为9.53±0.50log2。
- LaSota高免血清对LaSota病毒的HI滴度为9.73±0.36log2,对aSG10为8.87±0.38log2。
- 各血清均能中和异源病毒,但同源病毒的中和滴度始终比异源病毒高3至6倍。
- aSG10与LaSota的交叉反应R值为0.23,表明二者在同一血清型内存在较大抗原差异。
- 动物试验显示aSG10疫苗对基因VII型NDV的保护率显著高于LaSota疫苗,无论肌内或眼滴/鼻内攻毒途径。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Continued monitoring and evaluation of vaccine efficacy against prevalent or newly isolated strains has great importance in advising Newcastle disease (ND) immunization strategy. In this study, we systematically analysed the antigenic variation between genotype VII NDV aSG10 and the commercial vaccine strain LaSota, and assessed their efficacy against challenge with velogenic NDV by serological analysis and animal testing. We show that these two viruses are antigenically distinguishable; anti-NDV aSG10 hyper-immune sera demonstrated higher haemagglutination inhibition (HI) titres (11.13±0.30log2) against the aSG10 virus, compared with titres against LaSota (9.53±0.50log2). Conversely, the hyper-immune sera from LaSota showed higher HI titres against LaSota virus (9.73±0.36log2), but 2-fold lower HI titre against aSG10 (8.87±0.38log2). Each serum neutralised heterologous virus, but neutralisation titres were always 3- to 6-fold higher against its homologous strain than heterologous virus. The cross-reactivity R value between aSG10 and LaSota was 0.23, indicating that they are loosely related with major antigenic differences within a single serotype. The results of animal tests revealed that the aSG10 vaccine had a significantly higher protection rate than the LaSota vaccine against genotype VII NDV, regardless of intramuscular (IM) or eye drop/intranasal (ED/IN) route of SG10 challenge. Compared with IM administration, chicken flocks needed higher HI antibody levels to obtain sufficient protection when challenged by the natural ED/IN route. These results are highly informative for better control of ND in the poultry industry.
引用
- Yang HM, Zhao J, Xue J, et al. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV. Vaccine. 2016. PMID: 27889255. doi:10.1016/j.vaccine.2016.11.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。